Paul Tudor Jones Bridge Bio Pharma, Inc. Put Options Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
Put Options
1 transactions
Others Institutions Holding BBIO
# of Institutions
387Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.03 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$897 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$694 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$580 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$334 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.91B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...